Skip to main content

Advertisement

Log in

The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis

  • ENS TEACHING REVIEW
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Behçet’s Syndrome (BS) is a multi-system, vascular-inflammatory disease of unknown origin, involving the nervous system in a subgroup of patients. The growing clinical and imaging evidence suggests that primary neurological involvement in BS may be subclassified into two major forms: the first one, which is seen in the majority of patients, may be characterized as a vascular-inflammatory central nervous system (CNS) disease, with focal or multifocal parenchymal involvement mostly presenting with a subacute brainstem syndrome and hemiparesis; the other, which has few symptoms and a better neurological prognosis, may be caused by isolated cerebral venous sinus thrombosis and intracranial hypertension. These two types rarely occur in the same individual, and their pathogenesis is likely to be different. Isolated behavioral syndromes and peripheral nervous system involvement are rare, whereas a nonstructural vascular type headache is relatively common and independent from neurological involvement. Neurologic complications secondary to systemic involvement of BS such as cerebral emboli from cardiac complications of BS and increased intracranial pressure due to superior vena cava syndrome, as well as neurologic complications related to BS treatments such as CNS neurotoxicity with cyclosporine and peripheral neuropathy with the use of thalidomide or colchisin are considered as secondary neurological complications of this syndrome. As the neurological involvement in this syndrome is so heterogeneous, it is difficult to predict its course and prognosis, and response to treatment. Currently, treatment options are limited to attack and symptomatic therapies with no evidence for the efficacy of any long term preventive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akbulut L, Gur G, Bodur H, Alli N, Borman P (2007) Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Clin Rheumatol 26:1240–1244

    Article  PubMed  Google Scholar 

  2. Akman-Demir G, Bahar S, Baykan-Kurt B, Gürvit IH, Serdaroğlu P (1996) Intracranial hypertension in Behçet’s Disease. Eur J Neurol 3:66–70

    Google Scholar 

  3. Akman-Demir G, Serdaroğlu P, Tasçi B and the Neuro-Behçet Study Group (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. Brain 122:2171–2181

    Article  PubMed  Google Scholar 

  4. Aktaş EG, Kaplan M, Ozveren MF (2008) Basilar artery aneurysm associated with Behçet’s Disease: a case report. Turk Neurosurg 18:35–38

    PubMed  Google Scholar 

  5. Al-Araji A, Sharquie K, Al-Rawi Z (2003) Prevalence and patterns of neurological involvement in Behçet’s disease: a prospective study from Iraq. J Neurol Neurosurg Psychiatry 74:608–613

    Article  PubMed  CAS  Google Scholar 

  6. Atabay C, Erdem E, Kansu T, Eldem B (1992) Eales — disease with internuclear ophthalmoplegia. Ann Ophthalmol 24:267–270

    PubMed  CAS  Google Scholar 

  7. Atasoy HT, Tunc TO, Unal AE, Emre U, et al. (2007) Peripheral nervous system involvement in patients with Behçet disease. The Neurologist 13:225–230

    Article  PubMed  Google Scholar 

  8. Aykutlu E, Baykan B, Serdaroğlu P, et al. (2002) Epileptic seizures in Behçet disease. Epilepsia 43:832–835

    Article  PubMed  Google Scholar 

  9. Aykutlu E, Baykan B, Akman-Demir G, Topcular B, Ertas M (2006) Headache in Behçet’s disease. Cephalalgia 26:180–186

    Article  PubMed  CAS  Google Scholar 

  10. Bahar S, Çoban O, Gürvit H, Akman-Demir F, Gökyiğit A (1993) Spontaneus dissection of the extracranial vertebral artery with spinal subarachnoid hemorrhage in a patient with Behçet’s disease. Neuroradiology 35:352–354

    Article  PubMed  CAS  Google Scholar 

  11. Behçet H (1937) Uber residivierende, aphtöse, durch ein virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Derm Woschenscr 105:1152–1157

    Google Scholar 

  12. Bogdanova D, Milanov I, Georgiev D (1998) Parkinsonian syndrome as a neurological manifestation of Behçet’s disease. Can J Neurol Sci 25:82–85

    PubMed  CAS  Google Scholar 

  13. Bussone G, La Mantia L, Boiardi A, Giovannini P (1982) Chorea in Behçet’s Syndrome. J Neurol 227:89–92

    Article  PubMed  CAS  Google Scholar 

  14. Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H (1998) Urologic screening for men with Behçet’s syndrome. Urology 52:863–865

    Article  PubMed  CAS  Google Scholar 

  15. Fujikawa K, Aratake K, Kawakami A, Aramaki T, et al. (2007) Successful treatment of refractory neuro-Behçet’s disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheum Dis 66:136–137

    Article  PubMed  CAS  Google Scholar 

  16. Gardner RC, Schmahmann JD (2008) Ataxia and cerebellar atrophy — a novel manifestation of neuro-Behçet disease? Mov Disord 23(2):308–309

    Article  Google Scholar 

  17. Goodwin J (2008) The Vogt-Koyanagi-Harada syndrome. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com. Accessed 1 August 2008

  18. Green AL, Mitchell PJ (2000) Spinal cord Neurobehçet’s disease detected on magnetic resonance imaging. Australasian Radiology 44:201–203

    Article  PubMed  CAS  Google Scholar 

  19. Hadfield MG, Aydın F, Lippman HR, Sanders KM (1997) Neuro-Behçet’s disease. Clin Neuropathol 16:55–60

    PubMed  CAS  Google Scholar 

  20. Haghighi AB, Rahman P, Ali-Reza N (2007) The pathological presentations of neuro-Behçet disease: A case report and review of the literature. The Neurologist 13:209–214

    Article  PubMed  Google Scholar 

  21. Haghighi AB, Aflaki E, Ketabchi L (2008) The prevalence and characteristics of different types of headache in patients with Behçet’s disease, a case-control study. Headache 48:424–429

    Article  Google Scholar 

  22. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gül A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H (2008) EULAR recommendations for the management of Behçet’s disease: report of a task force of the European Standing Committee for International Clinical Sstudies Including Therapeutics (ESCISIT). Ann Rheum Dis 67(12):1656–1662

    Article  PubMed  CAS  Google Scholar 

  23. Hatzitolios A, Savopoulos C, Ntaios G, Tsirogianni E, Baltatzi M, Apostolopoulou M, Dimitrakoudi E (2008) Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-Behçet disease. Neurologist 14:77

    Article  PubMed  Google Scholar 

  24. Hirohata S, Suda H, Hashimoto T (1998) Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behçet’s disease. J Neurol Sci 14(159):181–185

    Article  Google Scholar 

  25. Hirose M, Ikeuchi T, Hayashi S, et al. (2006) A possible variant of neuro-Behçet disease presenting with chronic progressive ataxia without mucocutaneo-ocular symptoms. Rheumatol Int 27:61–66

    Article  PubMed  Google Scholar 

  26. Hisanaga K, Iwasaki Y, Itoyama Y (2005). Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology 64:1756–1761

    Article  PubMed  Google Scholar 

  27. Hisanaga K (2007) Neuro-neutrophilic disease: neuro-Behçet disease and neuro-Sweet disease. Intern Med 46:153–154

    Article  PubMed  Google Scholar 

  28. Hiwatashi A, Garber T, Moritani T, et al. (2003) Diffusion-weighted MR imaging of neuro-Behçet’s disease: a case report. Neuroradiology 45:468–471

    Article  PubMed  Google Scholar 

  29. Houman MH, Hamzaoui-B’Chir S, Ben Ghorbel I, et al. (2002) Neurologic manifestations of Behçet’s disease: analysis of a series of 27 patients. Rev Med Interne 23:592–606

    Article  PubMed  CAS  Google Scholar 

  30. Huang WS, Chiu PY, Kao A, et al. (2002) Decreased cerebral blood flow in neuro-Behçet’s syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging — a preliminary report. J Neuroimaging 12:355–359

    Article  PubMed  Google Scholar 

  31. International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    Google Scholar 

  32. International Study Group for Behçet’s disease (1992) Evaluation of diagnostic (classification) criteria in Behçet’s disease- towards internationally agreed criteria. Br J Rheumatol 31:299–308

    Google Scholar 

  33. Kang DW, Chu K, Cho JY, et al. (2001) Diffusion-weighted magnetic resonance imaging in neuro-Behçet’s disease. J Neurol Neurosurg Psychiatry 70:412–413

    Article  PubMed  CAS  Google Scholar 

  34. Kansu E (1996) Endothelial cell dysfunction in Behçet’s disease. In: Ansell BM, Bacon PA, Lie JT, Yazıcı H (eds) Vasculitides. London, Chapman&Hall, pp 207–221

  35. Kansu T, Kirkali P, Kansu E, Zileli T (1989) Optic neuropathy in Behçet’s disease. J Clin Neuro Opthalmol 9:2772–2780

    Google Scholar 

  36. Kantarci O, Siva A (2006) Behçet’s disease: diagnosis and management (Chapter 96). In: Noseworthy J (ed) Neurological Therapeutics: Principles and Practice. Second edition. Informa Healthcare, pp 1196–1206

  37. Karandreas N, Tsivgoulis G, Zambelis T, Kokotis P, Rapidi A, Petropoulou K, Spengos K (2007) Urinary frequency in a case of Neuro-Behçet disease involving the brainstem — clinical, electrophysiological and urodynamic features. Clin Neurol Neurosurg 109:806–810

    Article  PubMed  Google Scholar 

  38. Karatas GK, Onder M, Meray J (2002) Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 22:155–159

    Article  PubMed  Google Scholar 

  39. Kececi H, Akyol M (2001) P300 in Behçet’s patients without neurological manifestations. Can J Neurol Sci 28:66–69

    PubMed  CAS  Google Scholar 

  40. Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2171–2181

    Article  Google Scholar 

  41. Kidd D (2006) The prevalence of headache in Behçet’s syndrome. Rheumatology 45:621–623

    Article  PubMed  CAS  Google Scholar 

  42. Kikuchi S, Niino M, Shinpo K, et al. (2002) Intracranial hemorrhage in neuro-Behçet’s syndrome. Intern Med 41:692–695

    Article  PubMed  Google Scholar 

  43. Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive Neuro-Behçet’s syndrome. J Neurol Sci 272:99–105

    Article  PubMed  CAS  Google Scholar 

  44. Kizilkilic O, Albayram S, Adaletli I, et al. (2003) Endovascular treatment of Behçet’s disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 45:328–334

    PubMed  Google Scholar 

  45. Koç Y, Güllü I, Akpek G, et al. (1992) Vascular involvement in Behçet’s disease. J Rheumatology 19:402–410

    Google Scholar 

  46. Koçer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V (1999) CNS involvement in Neuro-Behçet’s syndrome: an MR study. AJNR 20:1015–1024

    PubMed  Google Scholar 

  47. Kotake S, Higashi K, Yoshikawa K, Sasamato Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology 106:586–589

    Article  PubMed  CAS  Google Scholar 

  48. Kotter I, Gunaydin I, Batra M, Vonthein R, Stubiger N, Fierlbeck G, Melms A (2006) CNS involvement occurs more frequently in patients with Behçet’s disease under cyclosporin A than under other medications results of a retrospective analysis of 117 cases. Clin Rheumatol 25:482–486

    Article  PubMed  Google Scholar 

  49. Krausea I, Weinberger A (2008) Behçet’s disease. Curr Opin Rheumatol 20:82–87

    Article  Google Scholar 

  50. Krespi Y, Akman-Demir G, Poyraz M, Tugcu B, Coban O, Tuncay R, Serdaroğlu P, Bahar S (2001) Cerebral vasculitis and ischaemic stroke in Behçet’s disease: report of one case and review of the literature. Eur J Neurol 8:719–722

    Article  PubMed  CAS  Google Scholar 

  51. Kural-Seyahi E, Fresko I, Seyahi N, et al. (2003) The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60

    Article  PubMed  Google Scholar 

  52. Kurtzke JF (1983) Rating neurological impairment in MS: An expended disability status scale (EDSS). Neurology 33:1444–1452

    PubMed  CAS  Google Scholar 

  53. Lakhanpal S, O’Duffy JD, Lie JT (1998) Pathology. In: Plotkin GR, Calabro JJ, O’Duffy JD (eds) Behçet’s disease. A contemporary synopsis. Futura, New York, pp 101–142

  54. Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G (2003) Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet’s syndrome. Ann Rheum Dis 62:280–281

    Article  PubMed  CAS  Google Scholar 

  55. Lannuzel A, Lamaury I, Charpentier D, Caparros-Lefebvre D (2002) Neurological manifestations of Behçet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249:410–418

    Article  PubMed  Google Scholar 

  56. Matsuo K, Yamada K, Nakajima K, Masanori Nakagawa (2005) Neuro-Behçet disease mimicking brain tumor. AJNR Am J Neuroradiol 26:650–653

    PubMed  Google Scholar 

  57. Miller DH, Ormerod IEC, Gibson A, DuBoulay EPGH, Rudge P, McDonald WI (1987) MRI brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29:226–23l

    Article  PubMed  CAS  Google Scholar 

  58. Mitsui Y, Mitsui M, Urakami R, Kihara M, Takasahi M, Kusunoki S (2005) Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to icroemulsion formulation. Int Med 44:149–152

    Article  Google Scholar 

  59. Monastero R, Mannino M, Lopez G, et al. (2003) Prevalence of headache in patients with Behçet’s disease without overt neurological involvement. Cephalalgia 23:105–108

    Article  PubMed  CAS  Google Scholar 

  60. Morrissey SP, Miller DH, Harmszewski R, et al. (1993) Magnetic resonance imaging of the central nervous system in Behçet’s disease. Eur Neurol 33:287–293

    Article  PubMed  CAS  Google Scholar 

  61. Namer IJ, Karabudak R, Zileli T, et al. (1987) Peripheral nervous system involvement in Behçet’s Disease. Eur Neurol 26:235–240

    Article  PubMed  CAS  Google Scholar 

  62. Nobili F, Cutolo M, Sulli A, et al. (2002) Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet’s disease. Ann N Y Acad Sci 966:409–414

    Article  PubMed  CAS  Google Scholar 

  63. O’Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet’s disease. Am J Med 76:75–84

    Article  PubMed  Google Scholar 

  64. O’Duffy JD (1990) Vasculitis in Behçet’s disease. Rheum Dis Clin North Am 16:423–431

    PubMed  Google Scholar 

  65. Oktem-Tanor O, Baykan-Kurt B, Gurvit IH, Akman-Demir G, Serdaroğlu P (1999) Neuropsychological follow-up of 12 patients with neuro-Behçet disease. J Neurol 246:113–119

    Article  PubMed  CAS  Google Scholar 

  66. Özdoğan H (1994) Behçet’s syndrome in children. Rheumatology in Europe 23(Suppl 12):34

    Google Scholar 

  67. Patel AV, Stickler DE, Tyor WR (2007) Neurosarcoidosis. Curr Treat Options Neurol 9:161–168

    Article  PubMed  Google Scholar 

  68. Pellechia MT, Cuomo T, Striano S, et al. (1999) Paroxysmal dystonia in Behçet’s disease. Mov Disord 14:177–179

    Article  Google Scholar 

  69. Perniciaro C, Molina J (1991) Cerebrovascular aneurysms in patients with Behçet’s disease. In: O’Duffy JD, Kökmen E (eds) Behçet’s disease: Basic and clinical aspects. New York: Marcel Dekker, pp 119–123

  70. Park JH, Jung MK, Bang CO, Park MK, et al. (2002) Neuro-Behçet’s disease mimicking a cerebral tumor: a case report. J Korean Med Sci 17:718–722

    PubMed  Google Scholar 

  71. Park DM (2008) Neurosarcoidosis. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com, accessed August 1, 2008

  72. Ramachandran TR (2008) Cogan’s syndrome. In: Gilman S (ed) MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com, accessed August 1, 2008

  73. Ribi C, Sztajzel R, Delavelle J, Chizzolini C J (2005) Efficacy of TNF a blockade in cyclophosphamide resistant neuro-Behçet disease. Neurol Neurosurg Psychiatry 76:1733–1735

    Article  CAS  Google Scholar 

  74. Robinson WH, Genovese MC, Moreland LW (2001) Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 44:1977–1983

    Article  PubMed  CAS  Google Scholar 

  75. Sağduyu A, Sirin H, Oksel F, et al. (2002) An unusual case of Behçet’s disease presenting with bilateral internal carotid artery occlusion. J Neurol Neurosurg Psychiatry 73(3):343

    Article  PubMed  Google Scholar 

  76. Said G (2000) Sarcoidosis of the nervous system. Neurological manifestations in systemic diseases. ENS Teaching Course 12, Syllabus, pp 74–85

  77. Saip S, Siva A, Altıntas A, et al. (2005) Headache in Behçet’s syndrome. Headache 45:911–919

    Article  PubMed  Google Scholar 

  78. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291

    Article  PubMed  CAS  Google Scholar 

  79. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442–451

    Article  PubMed  Google Scholar 

  80. Sarui H, Maruyama T, Ito I, et al. (2002) Necrotising myositis in Behçet’s disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann Rheum Dis 61:751–752

    Article  PubMed  CAS  Google Scholar 

  81. Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of longstanding neuro-Behçet’s disease with infliximab in patients with refractory disease. J Rheumatol 32:181–118

    PubMed  Google Scholar 

  82. Schmolck H (2005) Large thalamic mass due to neuro-Behçet disease. Neurology 65:436

    Article  PubMed  Google Scholar 

  83. Serdaroğlu P, Yazici H, Özdemir C, et al. (1989) Neurological involvement in Behçet’s syndrome: a prospective study. Arch Neurol 46:265–269

    PubMed  Google Scholar 

  84. Serdaroğlu P (1998) Behçet’s disease and the nervous system. J Neurol 245:197–205

    Article  PubMed  Google Scholar 

  85. Serdaroğlu P (1989) Neuromuscular manifestations in the course of Behçet’s Disease. Acta Myologica 2:41–45

    Google Scholar 

  86. Siva A, Özdogan H, Yazici H, et al. (1986) Headache, neuro-psychiatric and computerized tomography findings in Behçet’s syndrome. In: Lehner T, Barnes CG (eds) Recent advances in Behçet’s disease. Royal Society of Medicine Service, London, pp 247–254

  87. Siva A, Necdet V, Yurdakul S, et al. (1991) Neuroradiological findings in Neuro-Behçet Syndrome. In: O’Duffy JD, Kökmen E (eds) Behçet’s disease: Basic and clinical aspects. Marcel Dekker, New York, pp 323–329

  88. Siva A, Altıntas¸ A (2000) Neuro-Behçet Syndrome. In Said G (ed) Intravenous Immunoglobulins in the Treatment of Neurological Disorders. Martin Dunitz Publishers, London, pp 115–126

  89. Siva A, Fresko I (2000) Behçet’s Disease. Current Treatment Options in Neurology 2:435–447

    Article  PubMed  Google Scholar 

  90. Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Kocer N, Yazici H (2001) Behçet’s disease: diagnostic & prognostic aspects of neurological involvement. J Neurol 248:95–103

    Article  PubMed  CAS  Google Scholar 

  91. Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451–468

    Article  PubMed  CAS  Google Scholar 

  92. Siva A, Altıntas¸ A, Saip S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17:347–357

    Article  PubMed  Google Scholar 

  93. Sener RN (2003) Neuro-Behçet’s disease: diffusion MR imaging and proton MR spectroscopy. Am J Neuroradiol 24:1612–1614

    PubMed  Google Scholar 

  94. Sfikakis PP, Markomichelakis N, Alpsoy E, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H (2007) Anti-TNF therapy in the management of Behçet’s disease: review and basis for recommendations. Rheumatology 46:736–741

    Article  PubMed  CAS  Google Scholar 

  95. St. Clair EW, McCallum RM (1999) Cogan’s syndrome. Curr Opin Rheumatol 11:47–52

    Article  PubMed  CAS  Google Scholar 

  96. Stigsby B, Bohlega S, McLean DR, Al-Kawi MZ (2000) Transcranial magnetic stimulation in Behçet’s disease: a cross-sectional and longitudinal study with 44 patients comparing clinical, neuroradiological, somatosensory and brain-stem auditory evoked potential findings. Clin Neurophysiol 111:1320–1329

    Article  PubMed  CAS  Google Scholar 

  97. Susac JO, Egan RA, Rennebohm RM, Lubow M (2007) Susac’s syndrome: 1975–2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci 257:270–272

    Article  PubMed  Google Scholar 

  98. Takeuchi A, Kodama M, Takatsu M, et al. (1989) Mononeruritis multiplex in incomplete Behçet’s Disease: A case report and the review of the literature. Clin Rheumatol 8:375–380

    Article  PubMed  CAS  Google Scholar 

  99. Tunc T, Ortapamuk H, Naldoken S, Ergun U, Ciliz D, Atasoy HT, Okuyucu E, Inan LE, Eksioglu M (2006) Subclinical neurological involvement in Behçet’s disease. Neurol India 54:408–411

    Article  PubMed  Google Scholar 

  100. Tunc R, Saib S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet’s syndrome. Ann Rheum Dis 63:1693–1694

    Article  PubMed  CAS  Google Scholar 

  101. Wechsler B, Vidailhet M, Bousser MG, et al. (1992) Cerebral venous sinus thrombosis in Behçet’s disease: Long term follow-up of 25 cases. Neurology 42:614–618

    PubMed  CAS  Google Scholar 

  102. Yazıcı H, Yurdakul S, Hamuryudan V (2001) Behçet disease [Vasculitis syndromes]. Curr Opin Rheumatol 13:18–22

    Article  PubMed  Google Scholar 

  103. Yazıcı H (2003) Behçet syndrome: an update. Curr Rheumatol Rep 5:195–219

    Article  PubMed  Google Scholar 

  104. Yazıcı H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nature Clinical Practice Rheumatology 3:151–155

    Google Scholar 

  105. Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroğlu P, Akman-Demir G (2007) Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol 14:729–737

    Article  PubMed  CAS  Google Scholar 

  106. Yesilot N, Shehu M, Oktem-Tanor O, et al. (2006) Silent neurological involvement in Behçet’s disease. Clin Exp Rheumatol 24:S65–S70

    PubMed  CAS  Google Scholar 

  107. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. (1997) Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411–422

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aksel Siva MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siva, A., Saip, S. The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. J Neurol 256, 513–529 (2009). https://doi.org/10.1007/s00415-009-0145-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-0145-6

Key words

Navigation